| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.29 | 0.08 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.09 |